APA citiranje

Dastmalchi, F., Karachi, A., Khattri, R., Merritt, M. E., Mitchell, D., & Rahman, M. (2017). METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS. Neuro Oncol.

Citação norma Chicago

Dastmalchi, Farhad, Aida Karachi, Ram Khattri, Matthew E. Merritt, Duane Mitchell, and Maryam Rahman. "METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS." Neuro Oncol 2017.

MLA citiranje

Dastmalchi, Farhad, et al. "METB-02. A SENSITIVE METABOLIC SIGNATURE TO PREDICT IMMUNE RESPONSE AFTER IMMUNOTHERAPY FOR BRAIN TUMORS." Neuro Oncol 2017.